-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Gk9E2uHqz52Qm9LXLuN0YA7fa3xRtr3veb4BaMmpKCqhvpdqhIqH88EoG0VWHBn0 8CfVz6n5b68qiILrN/JJ1g== 0000836687-06-000167.txt : 20060404 0000836687-06-000167.hdr.sgml : 20060404 20060404165916 ACCESSION NUMBER: 0000836687-06-000167 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060404 DATE AS OF CHANGE: 20060404 EFFECTIVENESS DATE: 20060404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SEPARATE ACCOUNT B OF ING USA ANNUITY LIFE INSURANCE CO CENTRAL INDEX KEY: 0000836687 IRS NUMBER: 410991508 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 033-59261 FILM NUMBER: 06738956 BUSINESS ADDRESS: STREET 1: 1475 DUNWOODY DRIVE STREET 2: SUITE 400 CITY: WEST CHESTER STATE: PA ZIP: 19380-2700 BUSINESS PHONE: 610-425-3400 MAIL ADDRESS: STREET 1: 1475 DUNWOODY DRIVE STREET 2: SUITE 400 CITY: WEST CHESTER STATE: PA ZIP: 19380-2700 FORMER COMPANY: FORMER CONFORMED NAME: SEPARATE ACCOUNT B OF ING USA ANNUITY & LIFE INSURANCE CO DATE OF NAME CHANGE: 20031230 FORMER COMPANY: FORMER CONFORMED NAME: SEPARATE ACCOUNT B OF GOLDEN AMERICAN LIFE INSURANCE CO DATE OF NAME CHANGE: 19930506 FORMER COMPANY: FORMER CONFORMED NAME: SPECIALTY MANAGERS SEPARATE ACCOUNT B DATE OF NAME CHANGE: 19910529 0000836687 S000000888 SEPARATE ACCOUNT B OF ING USA ANNUITY LIFE INSURANCE CO C000002520 ING GOLDENSELECT DVA PLUS C000002975 ING GOLDENSELECT GRANITE PRIMELITE 497 1 ingusarlnynotice2.htm PHASE III FUND SUBSTITUTION - NOTICE 2

ING USA Annuity and Life Insurance Company and its Separate Accounts B and EQ

 

ReliaStar Life Insurance Company of New York and its Separate Account NY-B

 

Supplement dated April 4, 2006, to your current variable annuity prospectus

 

This supplement updates certain information contained in your current variable annuity prospectus. Please read it carefully and keep it with your variable annuity prospectus for future reference.

 

NOTICE OF FUND SUBSTITUTIONS

 

Effective April 28, 2006, and pursuant to applicable regulatory approvals, ING USA Annuity and Life Insurance Company and ReliaStar Life Insurance Company of New York (the “Companies”) and ING USA Separate Accounts B and EQ and ReliaStar Life Insurance Company of New York Separate Account NY-B (the “Separate Accounts”) will replace the following funds in which the subaccounts of the Separate Accounts invest (the “Replaced Funds”) with certain other funds (the “Substitute Funds”) as follows:

 

Replaced Funds

Substitute Funds

Fidelity VIP Growth Portfolio – Service Class 2

ING FMR Earnings Growth Portfolio – Class S

ING FMR Earnings Growth Portfolio – Service Class 2

Greenwich Street Appreciation Portfolio

ING Fundamental Research Portfolio – Class I

PIMCO VIT StocksPlus Growth and Income Portfolio – Administrative Class

ING EquitiesPlus Portfolio – Class S

Putnam VT International Growth and Income – Class 1B

ING VP Index Plus International Equity Portfolio – Class S

 

Not all of the Replaced Funds may be available through your variable annuity contract. Please refer to your product prospectus for the list of Replaced Funds available to you.

 

Important Information about the Substitutions.

•

After April 28, 2006, the effective date of the substitutions, the subaccounts which invest in the Replaced Funds will no longer be available through your variable annuity contract.

•

Prior to the effective date of the substitutions and for thirty days thereafter you may transfer amounts allocated to a subaccount which invests in a Replaced Fund to any other subaccount or the fixed account free of charge and any such transfer will not count as a transfer when imposing any applicable restriction or limit on transfers.

•

On the effective date of the substitutions, all amounts you have allocated to the subaccount which invests in a Replaced Fund will automatically be reallocated to the subaccount which invests in a corresponding Substitute Fund. Thereafter, all future allocations directed to a subaccount which invests in a Replaced Fund will be automatically allocated to the corresponding Substitute Fund.

•

You will not incur any fees or charges or any tax liability because of the substitutions, and your policy/contract value immediately before the substitutions will equal your policy/contract value immediately after the substitutions.

•

The total expenses of each Substitute Fund are less than or equal to the total expenses of the corresponding Replaced Fund. The fees and expenses of each Substitute Fund are more fully described in the Substitute Fund’s prospectus.

•

The investment objective and policy of each Substitute Fund is substantially the same as, similar to or consistent with the investment objective and policy of the corresponding Replaced Fund. The investment objective of each Substitute Fund is more fully described in the Substitute Fund’s prospectus.

•

If you have not already received prospectuses for the Substitute Funds, they accompany this supplement. Read these prospectuses carefully before deciding what to do with amounts allocated to the subaccounts which invest in the Replaced Funds. If you need another copy of the prospectuses, please contact our Customer Service Center at 1-800-366-0066 and we will send them to you.

 

 

INGUSA-EQ-RLNY-139404

Page 1 of 2

April 2006

 

 


 

 

Substitute Fund Fees and Expenses. Please see the prospectuses for the Substitute Funds for more information concerning these fees and expenses.

 

Substitute Fund Investment Advisers/Subadvisers and Investment Objectives. The investment advisers/ subadvisers and investment objectives of the Substitute Funds are shown in your product prospectus and the prospectuses for the Substitute Funds. Please see the prospectuses for the Substitute Funds for more information concerning their investment advisers/subadvisers and investment objectives.

 

 

INGUSA-EQ-RLNY-139404

Page 2 of 2

April 2006

 

 

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----